(Q48840373)

16 February 2018

title

Fatigue and depression predict physician visits and work disability in women with primary Sjögren's syndrome: results from a cohort study (English)

1 reference

16 February 2018

1 reference

Gisela Westhoff

1

1 reference

16 February 2018

Thomas Dörner

series ordinal

2

1 reference

16 February 2018

Angela Zink

series ordinal

3

1 reference

16 February 2018

publication date

25 June 2011

1 reference

16 February 2018

published in

Rheumatology

1 reference

16 February 2018

volume

51

1 reference

16 February 2018

issue

2

1 reference

16 February 2018

page(s)

262-269

1 reference

16 February 2018

Pulmonary nodules as initial manifestation of primary Sjogren's syndrome

cites work

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER208

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER208

Subclinical synovitis in primary Sjögren's syndrome: an ultrasonographic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER208

Articular manifestations in primary Sjögren's syndrome: clinical significance and prognosis of 188 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER208

Xerostomia, xerogenic medications and food avoidances in selected geriatric groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER208

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER208

[Indications and options of new immune modulatory therapies for Sjögren's syndrome].

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER208

Experience with experimental biological treatment and local gene therapy in Sjogren's syndrome: implications for exocrine pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER208

New approaches in Sjögren's syndrome therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER208

Direct healthcare costs and predictors of costs in patients with primary Sjogren's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER208

Estimating indirect costs in primary Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER208

Primary Sjögren's Syndrome: health experiences and predictors of health quality among patients in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER208

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER208

Measurement of fatigue and discomfort in primary Sjogren's syndrome using a new questionnaire tool.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER208

Patient-reported outcomes including fatigue in primary Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER208

The PHQ-9: validity of a brief depression severity measure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER208

Predicting depression in rheumatoid arthritis: the signal importance of pain extent and fatigue, and comorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER208

Peripheral neuropathy in primary sjogren syndrome: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER208

Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER208

Depression, stress and immunological activation: the role of cytokines in depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER208

Cytokines and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER208

Depression in patients with subacute myelo-optico-neuropathy (SMON).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER208

Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER208

Neuropathy is associated with depression independently of health-related quality of life in Japanese patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER208

Peripheral nervous system manifestations of Sjögren syndrome: clinical patterns, diagnostic paradigms, etiopathogenesis, and therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER208

Measurement of horizontal inequity in health care utilisation using European panel data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER208

Depression als komorbide Störung in der primärärztlichen Versorgung

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKER208

10.1093/RHEUMATOLOGY/KER208

21 January 2018

Identifiers

DOI

1 reference

16 February 2018

release_c6yhoubnejf33b34umlv7ekseq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/c6yhoubnejf33b34umlv7ekseq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

16 February 2018